ANG Lifesciences India Ltd. engages in the manufacture and marketing of finished pharmaceutical formulations in a form of sterile dry powder for injection vials. The company is headquartered in Amritsar, Punjab. The company went IPO on 2017-09-08. The firm is engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials. The Company’s product portfolio includes antibiotics, antiulcerant, neutraceuticals, anticoagulants, glucocorticoids, anti-inflammatory, antifungal, antihistamines, antimalarial, and anesthetic. Its dosage forms manufactured by Company includes tablets, capsules, oral liquids, liquid injection, prefilled syringe (PFS), dry powder injection and external preparations. The Company’s manufacturing unit is situated at Village Kishan pura, Post office Manpura Baddi Nalagarh Road, Tehsil Nalagarh, District Solan, Himachal Pradesh. The firm manufactures its products in compliance with good manufacturing practices (GMP) requirements.
Loading chart…
This company hasn't held an earnings call in the last six months, so there's no recent commentary from management. Our deep dives are built on what management actually said, so we haven't prepared one.